IRCT20191104045328N1
Recruiting
Phase 3
Evaluation of the Effect of Oral fosfomycin Addition on Treatment of Patients with Klebsiella pneumoniae Carbapnemase Infections with Colistin
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Arak University of Medical Sciences
- Enrollment
- 62
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with Klebsiella Pneumoniae Carbapenemase infection diagnosed by reliable culture and admitted to the infectious ward of Vali Asr Hospital are studied.
Exclusion Criteria
- •Allergy to fosfomycin
- •Patients with renal failure
- •Hemodialysis Patients
- •Under 12 years age
- •Patients who have received antibiotics affecting KPC for the past 72 hours.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Efficacy of oral fosfomycin as a step down therapy after treatment for upper urinary tract infection caused by extended-spectrum b-lactamase-producing Escherichia colipper urinary tract infectionESBL-producing E. coliUpper urinary tract infectionAcute pyelonephritisOral fosfomycinStep down therapySwitching therapyTCTR20171021001Research department, Faculty of Medicine Siriraj Hospital, Mahidol University140
Not yet recruiting
Phase 3
Efficacy of oral fosfomycin trometamol for empirical treatment of acute cystitis in kidney transplant recipient: an open label randomized controlled trialAcute cystitis Kidney transplant recipientsCystitisKidney transplant recipientsFosfomycin trometamolTCTR20201027005Research department, Faculty of Medicine Siriraj Hospital, Mahidol University110
Active, not recruiting
Phase 1
Efficacy and safety of intravenous fosfomycin in prosthetic joint infection (PJI)Prosthetic joint infection of knee, hip or shoulderTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2016-002673-35-DEPRO-IMPLANT Foundation226
Active, not recruiting
Phase 1
Fosfomycin concentrations in blood in persons with prolonged treatment with fosfomyciEUCTR2018-000616-25-NL15
Completed
Phase 2
Pharmacokinetics of fosfomycin: a study in patients with prolonged treatment for urinary tract infectiobladder infectionUrinary tract infection1000401810046590NL-OMON46751HagaZiekenhuis12